Effects of heptanol on neurogenic contractions
The contractile response of the guinea-pig
vas deferens to tetanic stimulation of the hypogastric nerve was biphasic, as reported earlier (
Sneddon & Westfall, 1984;
Kennedy et al., 1996) with the rising phase of the slow phase overlapping the decay of the fast phase (
Figure 1). The response had the expected pharmacological profile, the fast phase being abolished selectively by the P
2x purinoceptor antagonist suramin (200
![](corehtml/pmc/pmcents/x2009.gif)
μ
M;
Sneddon, 1992), the slow phase selectively by the α
1 adrenoceptor antagonist prazosin (1
![](corehtml/pmc/pmcents/x2009.gif)
μ
M) and the entire response by a combination of prazosin and suramin (see
Figure 4A).
![Figure 1 Figure 1](picrender.fcgi?artid=1565808&blobname=126-0702307f1.gif) | Figure 1Effect of 2.0 mM heptanol on neurogenic contractions of the guinea-pig vas deferens in two tissues. (A) Tissue showing complete suppression of two phases and (B) showing only partial suppression of purinergic phase a: Control; b: after 10 min (more ...) |
![Figure 4 Figure 4](picrender.fcgi?artid=1565808&blobname=126-0702307f4.gif) | Figure 4Generation of myogenic contractions of the guinea-pig vas deferens. (A) Suppression of neurogenic force, generated by hypogastric nerve stimulation at 8 Hz in the presence of suramin and prazosin (S+P). a: Control; b,c: 40 and 70 min (more ...) |
Suppression of force
The effects of heptanol on contractile force were investigated in most trials at a concentration of 2.0
![](corehtml/pmc/pmcents/x2009.gif)
m
M. Effects at lower (0.5, 1.0
![](corehtml/pmc/pmcents/x2009.gif)
m
M) or higher (4.0
![](corehtml/pmc/pmcents/x2009.gif)
m
M) concentrations were qualitatively similar, though rates of onset were variable. 2.0
![](corehtml/pmc/pmcents/x2009.gif)
m
M seems to be the optimal concentration of heptanol for the reversible abolition of EJPs in the organ under investigation, the guinea-pig
vas deferens (see Discussion), hence this concentration was used so that effects on contractile and electrical activity could be compared.
In general, superfusion of 2.0
mM heptanol solution for about 20
min gradually suppressed both phases of the neurogenic contraction (Figure 1). In the majority of trials (seven out of nine), both phases were inhibited similarly. The peak force of the first phase was suppressed without change of shape by 83±7% (n=7) on 20
min exposure to heptanol. Inhibition of the second phase was more complex, as it developed irregular fluctuations during its suppression, as described in greater detail below.
Figure 1A shows results of a trial in which the inhibition was complete for both phases at 20
min (Figure 1A, c). The effect was completely reversed on washout with normal Krebs for about 20
min (Figure 1A, e). In the other two trials the purinergic phase was partly resistant to the action of heptanol, its force being suppressed by only 50% following 20
min of heptanol exposure, whereas the adrenergic phase was completely abolished during this interval (see Figure 1B, c).
Increase in latency of force and separation of the phases
In control contractions the latency between the start of stimulation and the onset of the purinergic phase was 0.83±0.11
![](corehtml/pmc/pmcents/x2009.gif)
s (
n=9). Exposure to 2.0
![](corehtml/pmc/pmcents/x2009.gif)
m
M heptanol for 20
![](corehtml/pmc/pmcents/x2009.gif)
min increased the latency of the first phase significantly (
P<0.05) to 1.58±0.30
![](corehtml/pmc/pmcents/x2009.gif)
s (
n=7). The change in latency is displayed in the superimposed and expanded traces of
Figure 2A and B, which show responses recorded during the progressive inhibition of contractions by heptanol, before their complete abolition.
![Figure 2 Figure 2](picrender.fcgi?artid=1565808&blobname=126-0702307f2.gif) | Figure 2(A,B) Comparison of control neurogenic response with that in the presence of heptanol. Note the increase in latency, separation of the two phases and oscillations in the second phase induced by heptanol. Stimulation carried out at 8 Hz (10 V, (more ...) |
The onset of the noradrenergic phase was more strikingly delayed by heptanol (Figure 2A). The latency of the second phase in control contractions is difficult to determine with certainty because its onset is obscured by the preceding purinergic phase. However, the latency of the second phase can reasonably be assumed to be similar to that of the first since both ATP and NA, the two neurotransmitters mediating the phases, are known to be released simultaneously from the innervation following stimulation, though the noradrenergic phase is slower to develop (von Kugelgen & Starke, 1994; von Kugelgen et al., 1994; Stjarne & Stjarne, 1995). On the basis of this assumption the latency of the second phase was increased from 0.83±0.11
s in controls to 14.93±1.23
s (n=7) following 20
min exposure to heptanol (Figure 2A).
Since the increase of latency of the second phase was much greater than that of the first phase, the induced suppression of contractile force was accompanied by a progressive temporal separation of the two phases. The extent of separation at 20
min exposure to heptanol was such that there was no longer any overlap between the phases (Figure 2A).
Since the first phase of contraction is EJP-dependent, the increase in latency of this phase suggests that EJPs inhibited by heptanol (Manchanda & Venkateswarlu, 1997) take longer to reach threshold for action potential generation. To test this, we recorded EJPs in the presence of heptanol at 8
Hz, the same frequency of stimulation as that employed in the contractile studies. In control conditions, EJPs at
5
Hz readily summate to reach action potential threshold and produce contractions (Blakeley et al., 1981). In the presence of heptanol, the development of threshold depolarization was considerably delayed, and in one trial EJPs at 8
Hz did not reach threshold in 8
s of stimulation (Figure 2C). When the frequency of stimulation was increased gradually beyond 8
Hz to about 70
Hz, an action potential and contraction were finally generated (Figure 2D). Threshold for regenerative excitation is achieved at higher frequencies of stimulation since a larger degree of summation results in a larger mean depolarization. Correspondingly in contractile studies, the heptanol inhibited neurogenic contraction, too, was partially restored by increasing the stimulus frequency to 70
Hz (not shown).
Oscillations in the noradrenergic phase
In addition to the remarkable increase of latency in the presence of heptanol, the second phase also developed, during its suppression, prominent, irregular oscillations in force, being split into an uncoordinated series of alternate contractions and relaxations. Examples of these oscillations are evident in
Figures 1A, b,d and
2A. The extent of variation of force during these oscillations could be as much as ~50% of the peak force developed (
Figure 1A, b), or just enough to cause a significant ripple during the second phase (e.g. in
Figure 1B, d). The effect was specific to heptanol action, since control contractions either before or after application of heptanol were seen not to possess such pronounced fluctuations, though a slight, but regular ripple could occasionally be observed (
Figures 1A, a,e and
2A).
A possible interpretation of the oscillations observed in the presence of heptanol is that they are the result of muscle action potentials triggered intermittently by residual purinergic EJPs which may not have been inhibited completely by heptanol. To confirm the nature of the transmitter responsible for the delayed response in the presence of heptanol, the vas was superfused with suramin (200
μM) before the application of heptanol. Suramin inhibited powerfully the first phase of contraction and a monophasic contraction remained, corresponding to the second, noradrenergic phase of the normal biphasic neurogenic contraction (Figure 3). These suramin-resistant contractions were affected by heptanol in the same way as the second (noradrenergic) phase of the normal neurogenic contraction, i.e. in suppression of force, induction of oscillations in force during suppression, and marked increase of latency of the same order (Figure 3). Thus these oscillations are likely to be due to effects exerted specifically on noradrenergic mechanisms by heptanol.
![Figure 3 Figure 3](picrender.fcgi?artid=1565808&blobname=126-0702307f3.gif) | Figure 3Persistence of heptanol-induced contractile oscillations in the second phase in the presence of suramin (200 μM). Exposure to suramin for 40 min inhibits profoundly the first (purinergic) phase of the neurogenic contraction, while (more ...) |
Effect of heptanol on myogenic contractions
Suppression of neurogenic contractions by heptanol can conceivably be explained on the basis of purely neuroinhibitory effects of this agent. To determine whether heptanol indeed affects muscle function independent of neuronal elements, we investigated its effect on myogenic contractions, which originate in the muscle without neuronal contribution. Neurogenic contractions were first eliminated by applying a combination of the P
2x purinoceptor antagonist suramin (200
![](corehtml/pmc/pmcents/x2009.gif)
μ
M) together with α
1 adrenoceptor antagonist prazosin (1
![](corehtml/pmc/pmcents/x2009.gif)
μ
M).
Figure 4A shows that this combination completely abolished neurogenic transmitter-mediated contractions.
To elicit myogenic contractions, stimulation was switched to the muscle stimulation electrodes using appropriate pulse parameters (see Methods), which elicited contractions of the type illustrated in Figure 4B, a. These contractions, since they arise despite the presence of suramin and prazosin, are therefore likely to be of purely myogenic origin. To confirm this, the same pair of electrodes was used to deliver stimulation selective for nerve stimulation (10
V, 5-ms pulses at 8
Hz). Figure 4B, b shows that in the presence of the antagonists, this stimulation failed to generate any detectable force, indicating that neurogenic contributions were entirely eliminated. The latency of the myogenic response (0.32±0.02
s, n=6) was about 60% less than that of the neurogenic response (0.83±0.11
s, n=9) (see Figure 4B, a). This is expected from the elimination of neuronal conduction, synaptic delay and time taken for the summation of EJPs to reach threshold for generation of muscle action potential.
Following the application of 2.0
mM heptanol for 20–30
min, peak myogenic force was almost entirely suppressed in all trials, by 98±1% (n=5) (Figure 5A,B,C). The reduction of force observed when using the long duration pulses required for myogenic contraction could possibly occur as a result of electrode polarization. However, the suppression of force persisted when stimulation was delivered after reversing electrode polarity (Figure 5D). This indicates that the suppression of the myogenic force was unrelated to electrode polarization and was indeed a heptanol mediated effect. The suppression was reversible on washout of heptanol (Figure 5E,F).
![Figure 5 Figure 5](picrender.fcgi?artid=1565808&blobname=126-0702307f5.gif) | Figure 5Reversible suppression of myogenic force by 2.0 mM heptanol. (A) Control; (B,C) 20 and 30 min respectively after application of heptanol. (D) absence of force generation following reversal of stimulation polarity using the same parameters (more ...) |